Grant: Idea to Innovation
University of Alberta
$9,975.00
The development of a concha electrode for electrocochleography (ECochG)
FY 2012-13
Summary
More than 600 million people suffer from hearing impairment and the hearing service is a billion dollar market. The impairment is commonly located at cochlea of the inner ear. The electrodes that are currently used to diagnose hearing problems linked to the cochlea and/or hearing nerves are placed in the ear canal, which sometimes is a painful and more invasive than an electrode placed outside the ear canal. The concha electrode technology described in this application can simultaneously and non-invasively measure electrical responses from the cochlea and hearing nerves. Compared to the ear canal electrodes, the concha electrode has many advantages: (i) it is easy to use and the electrode can be seen during use, (ii) it can be used if the ear canal has disorders or swelling due to inflammation or infection, (iii) it does not require extensively cleaning if the ear canal has some earwax, (iv) it can be used if the ear canal is too sensitive to touch, (v) it is suitable for use with infants, particularly if a child is too young to cooperate, (vi) it avoids injuries to the ear canal, and (vii) it saves time in placing the electrode. With these advantages, the concha electrode has many potential applications: (i) measuring cochlear responses, (ii) measuring nerve responses, (iii) baby hearing screening, (iv) assessing adult low-frequency cochlear function, (v) monitoring noise-induced hearing impairment, (vi) monitoring drug-induced hearing impairment, and (vii) monitoring age-related hearing loss change. This technology can be used everywhere in the world with a minimum of training and is going to be affordable, making it attractive to developing countries which are building up this health-care infrastructure. This market assessment will help identify the best way to develop this technology for clinical use. It will provide information from clinicians that will ensure the R&D funds used in the development of the concha electrode will be spent addressing problems that are directly relevant to the clinicians and patients, greatly increasing the chances of successful commercialization and widespread adoption of this beneficial innovation in health care for Canadians.
Program
Idea to Innovation
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
430507-2012
Name nom
Zhang, Ming
Department département
Speech Pathology and Audiology
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
9975
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
1100
Research subject group en
Structural engineering
Research subject group fr
Génie des structures
Research subject en
Structural engineering
Research subject fr
Génie des structures
Partie
1
Nb partie
1
Application title
The development of a concha electrode for electrocochleography (ECochG)
Keyword
NSERC
Application summary
More than 600 million people suffer from hearing impairment and the hearing service is a billion dollar market. The impairment is commonly located at cochlea of the inner ear. The electrodes that are currently used to diagnose hearing problems linked to the cochlea and/or hearing nerves are placed in the ear canal, which sometimes is a painful and more invasive than an electrode placed outside the ear canal. The concha electrode technology described in this application can simultaneously and non-invasively measure electrical responses from the cochlea and hearing nerves. Compared to the ear canal electrodes, the concha electrode has many advantages: (i) it is easy to use and the electrode can be seen during use, (ii) it can be used if the ear canal has disorders or swelling due to inflammation or infection, (iii) it does not require extensively cleaning if the ear canal has some earwax, (iv) it can be used if the ear canal is too sensitive to touch, (v) it is suitable for use with infants, particularly if a child is too young to cooperate, (vi) it avoids injuries to the ear canal, and (vii) it saves time in placing the electrode. With these advantages, the concha electrode has many potential applications: (i) measuring cochlear responses, (ii) measuring nerve responses, (iii) baby hearing screening, (iv) assessing adult low-frequency cochlear function, (v) monitoring noise-induced hearing impairment, (vi) monitoring drug-induced hearing impairment, and (vii) monitoring age-related hearing loss change. This technology can be used everywhere in the world with a minimum of training and is going to be affordable, making it attractive to developing countries which are building up this health-care infrastructure. This market assessment will help identify the best way to develop this technology for clinical use. It will provide information from clinicians that will ensure the R&D funds used in the development of the concha electrode will be spent addressing problems that are directly relevant to the clinicians and patients, greatly increasing the chances of successful commercialization and widespread adoption of this beneficial innovation in health care for Canadians.